Distinguished Neurologist to Join World Experts on Therapeutic Hypothermia at International Therapeutic Temperature Management Congress

Share Article

Two months from now, a unique and unprecedented global gathering of medical experts will convene to present and share ideas around how therapeutic temperature solutions lower the rate of mortality and raise the quality of life for critical patients. With heightened attention on the neurological benefits of therapeutic cooling, a leading investigator and surgeon will host industry-first discussions about research findings and innovative protocols in managed hypothermia as a treatment for spinal injury and paralysis, in addition to cardiac arrest.

News Image
Although it is too early to tell, the acute administration of cold saline in the emergency vehicle and the continued use of modest hypothermia following [a professional football player’s] severe spinal cord injury may have led to reduced spinal cord swelling and the attenuation of several secondary injury mechanisms

Two months from now, a unique and unprecedented global gathering of medical experts will convene to present and share ideas around how therapeutic temperature solutions lower the rate of mortality and raise the quality of life for critical patients. With heightened attention on the neurological benefits of therapeutic cooling, a leading investigator and surgeon will host industry-first discussions about research findings and innovative protocols in managed hypothermia as a treatment for spinal injury and paralysis, in addition to cardiac arrest.

W. Dalton Dietrich, III, PhD, Scientific Director of the Miami Project to Cure Paralysis, Distinguished Chair in Neurosurgery, and Vice Chair for Research in Neurosurgery at the University of Miami’s Miller School of Medicine, will be part of a group of doctors, scientific directors, academic researchers, and emergency professionals participating in the 1st Annual International Therapeutic Temperature Management Congress in December. Experts will represent countries progressing in patient temperature modulation practices, including the US, Canada, Australia, and the Netherlands.

It is widely demonstrated that cardiac-arrest patients receiving controlled cooling therapy at critical injury or illness onset are more likely to survive a hospital stay, and be discharged with greater neurological function. While much has been achieved to date in documenting the impact of moderate hypothermia on cardiac arrest, tracking the same advantages to spinal damage scenarios remains relatively new territory.

A recent, highly public sports injury may have established a unique opportunity. “Although it is too early to tell, the acute administration of cold saline in the emergency vehicle and the continued use of modest hypothermia following [a professional football player’s] severe spinal cord injury may have led to reduced spinal cord swelling and the attenuation of several secondary injury mechanisms,” said Dr. Dietrich.

Dr. Dietrich continued, “This important conference will bring together the major players in the field of therapeutic hypothermia to discuss the latest experimental and clinical data. The use of modest hypothermia to treat different patient populations continues to gain momentum. Events like this one are necessary for investigators to exchange information and to create treatment guidelines that limit potential risk factors and improve functional outcomes in our patients.”

Cincinnati Sub-Zero (CSZ), a developer of advanced patient temperature management systems, including highly effective and efficient cooling products, is an unrestricted educational grant sponsor for the event. “Collaborative work is absolutely necessary to advancing the treatment,” said Mark Beran, Vice President and General Manager of CSZ Medical. “The congress will play an instrumental role in facilitating further development of a growing worldwide medical community in support of these remarkable therapies.”

The 1st Annual International Therapeutic Temperature Management (TTM Congress) will be held in Cancun, Mexico from December 4-7, 2007. The TTM Congress will convene experts from around the world to review practices and research in therapeutic hypothermia and patient temperature modulation. More information on the event, including registration information, is available at http://www.ttmcongress.com.

About Cincinnati Sub-Zero and Cincinnati Sub-Zero, Medical Division

The parent of three separate divisions, Cincinnati Sub-Zero (CSZ) is a leading manufacturer and provider of temperature management products for medical and industrial needs. Cincinnati Sub-Zero, Medical Division has delivered patient temperature management systems to healthcare professionals since 1963, always designed with the patient in mind. The complete line of products includes therapeutic heat therapy, cold therapy units along with a complete line of warming blankets and cooling blankets for body temperature regulation and hyper-hypothermia treatment. Please visit http://www.cszmedical.com to learn more about CSZ Medical.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Contact

Watermark Research Partners
Robin Piazza
317.576.1818
rpiazza(at)watermarkrs.com
http://www.watermarkrs.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Robin Piazza
Visit website